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Kigelia pinnata (Bignoniaceae), colloquially called the
Sausage Tree, or Worsboom, on account of its large
fruits, has a variety of medicinal uses throughout Africa
where it grows as an endemic species in many areas.
Chemical examination has resulted in the isolation of
iridoids and naphthoquinoids as important secondary
metabolites but flavonoids and lignans have also been
isolated. Investigation into the biological activity of K.
pinnata has focussed on its antibacterial activity and its
cytotoxic effects against cancer cell lines. These are
related to the traditional uses of bark and fruit extracts
for treating diseases caused by micro-organisms and as
a remedy for skin cancer. The iridoids and naphtho-
quinones have been shown to display antibacterial
activity and also the ability to inhibit the growth of
yeasts. Considerable in vitro cytotoxicity has been
demonstrated by extracts of the fruits and barks and the
iridoid-related compound norviburtinal and the naph-
thoquinone isopinnatal have been shown to be two of
the compounds responsible. Although little ethnophar-
macological evidence exists, the naphthoquinones are
active against several  protozoal species associated
with disease. The compounds also show cytotoxicity
against mammalian cell lines. More research is needed
to investigate further the reputed effects on the skin of
extracts of this plant.
Introduction
Kigelia pinnata (Jacq.) D.C. is also commonly referred to in
the scientific literature as K. africana (Lam.) Benth. Kigelia is
now generally considered to be a highly variable monospe-
cific genus of the Bignoniaceae (Mabberley 1987), although
several species have been reported in the past (Neuwinger
1996). It is a reasonably large tree, attaining 20m in height
and grows in moist places, such as river banks, throughout
the savannah areas of tropical Africa. It has a large range
from Senegal across to Ethiopia and south to the northern
parts of South Africa.
K. pinnata is often planted in botanical gardens in the trop-
ics because of its spectacular fruits. These can weigh sev-
eral kilograms and resemble large sausages, hence giving
the tree its common English name of ‘Sausage Tree’. In
Afrikaans it is known as ‘Worsboom’, ‘Kalabasboom’ or
‘Komkommerboom’, in Zulu as ‘Umfongothi’, in Northern
Sotho as ‘Modukguhlu’ and in Venda as ‘Muvevha’
(Hutchings et al. 1996, Van Wyk et al. 1997). Over one hun-
dred other African local names are given by Neuwinger
(1996), emphasising its widespread distribution within Africa
and also its ethnobotanical importance.
Ethnobotanical uses of K. pinnata with particular refer-
ence to its medicinal uses
K. pinnata is mentioned in all the reference books dealing
with economic plants of the parts of Africa where it grows.
Details can be found in Irvine (1961), Watt and Breyer-
Brandwijk (1962), Burkill (1985), Hutchings et al. (1996) and
Neuwinger (1996). The account of uses which is given
below is not exhaustive but is a summary of those most rel-
evant to the laboratory studies which have been carried out.
A comprehensive account of the ethnobotany of K. pinnata
can be located on the SEPASAL database of the Royal
Botanic Gardens Kew at:
http://www.rbgkew.org.uk/ceb/sepasal.
There are some uses which are widespread but some are
more localised. If a particular medicinal use is well-refer-
enced but is confined to a particular geographical area, it
may indicate that chemical varieties may exist, and this may
support those who contend that several species should be
recognised. However, no systematic study of the chemistry
of the species from different areas has yet been carried out
so that, at present, this hypothesis is confined to the realms
of speculation.
The leaves are not one of the parts of the plant which fea-
ture prominently in its traditional use. In West Africa they are
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used to make a drink to treat gastrointestinal ailments
(Burkill 1985, Irvine 1961).
The use of a macerate in water of the stembark as a treat-
ment for dysentery and for sexually-transmitted diseases
(STDs) such as syphilis is reported from many different
areas. Another common use of the bark is as a powder or a
water macerate to treat sores or fungal infections on the
skin. In West Africa alone the bark extract is used to treat
snakebite, mainly it appears to soften the skin before the
administration of other plant-based remedies (Burkill 1985).
In the same geographical area the bark has some reputation
as a treatment for convulsions and this relates to similar
uses in east Africa (Neuwinger 1996). In southern Africa the
bark is used for ulcers, pneumonia and toothache
(Hutchings et al. 1996).
The rootbark is used in much the same way as the stem-
bark. In west Africa there are additional applications in get-
ting rid of tapeworms and for gynaecological complaints
(Burkill 1985).
The fruits are the most commonly used parts of the plants.
There are several reports of the poisonous nature of the
unripe fruit but no scientific work has been carried out to
determine the basis for this. Some uses are fairly prosaic
such as the making of childrens’ dolls in Tanzania or as sup-
port over a fire for cooking pots in Malawi (Burkill 1985).
However, the fruits are extensively used, probably because
of their shape and size, for a large number of reasons asso-
ciated with indigenous religious and religio-medical prac-
tices. Thus the fruits are used as fetishes in many areas and
rubbed to enlarge breasts or penises and in other rituals
associated with increased fecundity, fertility and improved
milk flow (Neuwinger 1996).
The ripe fruit is very fibrous and is not used to any extent
by humans as a food, except in famine situations, although it
is eaten by wild animals such as squirrels (Burkill 1985). In
Tanzania, as in several other parts of Africa, an extract of the
fruit is used to flavour beer and to increase its potency,
thought to be due to the production of amyl alcohol (pentanol)
during the fermentation (Watt and Breyer-Brandwijk 1962).
The fruit also is reported quite widely to have effects which
are more clearly medicinal rather than those associated with
superstition or explainable by the Doctrine of Signatures (a
theory originating from mediaeval Europe which proposed
that the uses of a plant in disease were shown by its appear-
ance e.g. the shape of the fruits of K. pinnata resemble an
erectile penis and were therefore aphrodisiac). A decoction is
used in many parts of Africa as a laxative and the powdered
dried fruit is used extensively as a dressing for wounds,
ulcers and sores. Commercial preparations for treating the
skin are marketed in Zimbabwe and South Africa but no med-
ical claims are made. However, it is widely believed that
these creams reduce pigmentation in freckles and help sores
to heal, the latter effect being possibly related to traditional
wound-healing and antibacterial effects.
The fruit infusion is also taken as a remedy for rheumatism
and back pains in Ivory Coast and some other countries
(Burkill 1985). Of particular interest is the use of the fruit to
treat cancer which is reported from Togo (Neuwinger 1996),
and especially from southern Africa where it has a consider-
able reputation for being effective against solar keratoses,
which may develop into skin cancer, (Hutchings et al. 1996)
and against less-defined cancer of the skin (Neuwinger 1996).
Chemical constituents of Kigelia pinnata
It is important to know which secondary metabolites are
found in plants because these may provide a basis for its tra-
ditional uses, particularly if they are the same as, or similar
in structure to, compounds from other species which display
relevant activity. To some extent, the type of compounds
likely to be present can be deduced from its taxonomic posi-
tion and this can be seen to be the case with K. pinnata,
which is a member of the Bignoniaceae, a family noted for
the occurrence of iridoids and naphthoquinones in many
constituent genera (Hegnauer 1964).
The iridoids (Figure 1) found in Kigelia correspond to the 9-
carbon skeleton type, e.g. catalpol 1, found in other mem-
bers of the Bignoniaceae. The major iridoids found in the
rootbark and stembark of K. pinnata are the catalpol deriva-
tives esterified  with phenylpropanoic acid derivatives at C-6
and these were identified as specioside 2, verminoside 3
and minecoside 4 (Houghton and Akunyili 1993).
Norviburtinal 5, generally considered to be a breakdown
product of the iridoids, has also been isolated from the roots,
Figure 1: Iridoids from Kigelia pinnata
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stembark and fruits (Joshi et al. 1982, Jackson et al. 2000).
In some South American species of the Bignoniacae,
naphthoquinones are present in quite large amounts and
give a colour to the wood. The characteristic compound of
several species of Tabebuia, a related genus of the
Bignoniaceae, is lapachol 6 (Figure 2), which is known to be
cytotoxic and at one time was considered as a treatment for
cancer by the National Institute of Health in the USA. It has
been reported present in small amounts in the wood, and
roots of K. pinnata by several investigators (Binutu et al.
1996, Govindachari et al. 1971, Inoue et al. 1981, Joshi et
al. 1982).
Three furanonaphthoquinones kigelinone 7, 2-acetylnaph-
tho[2,3-b]furan-4,9-quinone 8 (Binutu et al. 1996) and 2-(1-
hydroxyethyl)naphtho[2,3-b]furan-4,9-quinone 9 (Moideen
et al. 1999) have been isolated from K. pinnata stembark
and rootbark (Figure 2).
Two pairs of monoterpenoid-naphthoquinone compounds
(Figure 2) named pinnatal 10 and isopinnatal 11 and kigeli-
nol 12 and isokigelinol 13, unique to K. pinnata, have been
isolated from the roots and fruit (Joshi et al. 1982, Akunyili
and Houghton 1993).
The flavonol quercetin 14 and four flavonones luteolin 15,
its 6-OH analogue 16 and corresponding 7-O-glucosides 17,
18 were isolated from the leaves and fruits of K. pinnata (El-
Sayyad 1981). Three isocoumarins 6-methoxymellein 19,
kigelin 20 and 6-demethylkigelin 21 were isolated from the
roots of the plant (Govindachari et al. 1971). The lignan kige-
liol 22 was isolated from the wood (Inoue et al. 1981) and
was the only lignan reported until 1999 when the neolignan
balanophonin 23 was isolated from the stembark (Moideen
et al. 1999) (Figure 3).
The common steroids β-sitosterol 24 and stigmasterol 25
have been isolated by various workers from the bark and
root of K. pinnata (Govindachari et al. 1969, Inoue et al.
1981, El-Sayyad 1981, Joshi et al. 1982, Jackson et al.
2000). γ-sitosterol 26 was reported present in K. pinnata fruit
by Khan (1998) (Figure 4).
Biological studies on K. pinnata
Most of the studies on the biological activity of K. pinnata
extracts and constituents have been connected in some way
to its traditional uses.
The use of extracts of K. pinnata bark in many parts of
Africa as a treatment for STDs is mentioned above. An
unpublished ethnobotanical survey amongst traditional heal-
ers amongst the Igbos in south eastern Nigeria conducted
Figure 2: Naphthaquinoids from Kigelia pinnata Figure 3: Flavonoids and other shikimate-derived compounds  from
Kigelia pinnata
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by Dr Akunyili from University of Nigeria, Nsukka, revealed
that they use an aqueous or dilute alcohol extract of K. pin-
nata rootbark as a treatment for STDs. Extracts of the roots
equivalent to those obtained using the traditional methods
were found to contain the iridoids specioside 2 and mineco-
side 4 as major constituents. The extracts, as well as two of
the isolated iridoids, were tested and also their 1/10 and
1/100 dilutions, against four representative species of bac-
teria viz. Stapylococcus aureus, Bacillus subtilis,
Escherrichia coli and Pseudomonas aeruginosa, and the
yeast Candida albicans in the absence and presence of the
enzyme emulsin. This enzyme converts catalpol-type iri-
doids to their more antimicrobially active non-sugar contain-
ing aglycones. The growth of the organisms in culture broth
was assessed by measuring the turbidity of the solution
(Akunyili et al. 1991). The results showed that the aqueous
extract had strong activity, even in the absence of emulsin,
against all the bacteria tested but especially against the
yeast C. albicans. This is of interest since Candida infections
are common opportunistic infections of the genito-urinary
tract and the traditional use of this plant extract might allevi-
ate this in sexually-transmitted diseases. Both isolated iri-
doids also showed activity in the same way but did not seem
to account for all the activity shown by the extracts.
Further studies using a wider range of micro-organisms
and compounds showed that the naphthoquinoids from the
stembark also had a moderate antimicrobial effect.
Kigelinone 7 and isopinnatal 11 were the most active com-
pounds with minimum inhibitory concentrations (MIC) not
less than 50μg mL-1 against any other the bacteria or yeasts
tested (Binutu et al. 1996). However, it should be pointed out
that the naphthoquinoids are unlikely to exist in sufficiently
high concentrations in aqueous or dilute alcohol extracts
such as those used in traditional medicine.
There thus seems some evidence that extracts of the
roots and stembark of K. pinnata possess antimicrobial
activity. As well as some justification for their traditional uses
against genito-urinary infections, this observed effect may
also be relevant to the use of such preparations in skin con-
ditions which might be caused by micro-organisms such as
dermatophytes (ringworm and associated conditions) or
bacteria (complications of acne, boils and similar diseases).
As well as reports in the literature which are mentioned
above, several independent anecdotal reports were
received by our group of the usefulness of Kigelia extract in
treating ‘skin cancer’, particularly amongst the white popula-
tion in southern Africa. Although the nature of the extract and
the part of the plant from which it was derived were at first
unclear, further investigations revealed that a 50% ethanolic
extract of the fresh fruits was most commonly used. Other
findings included the information that the white population
had learnt of this use of the plant from the indigenous ethnic
groups in Zimbabwe and surrounding countries, a fact sup-
ported by literature reports (Neuwinger 1996, Hutchings et
al. 1996). The precise definition of ‘skin cancer’ was unclear
and there is a range of diseases with different severity which
could be classified as such. These range from erodent
ulcers, which are common in fair-skinned persons exposed
to bright sunlight, and are not malignant per se but often
develop into malignant growth, to melanoma which is often
refractory to treatment, particularly once it has metastasised.
As well as the ethnobotanical evidence, there were other
indicators that Kigelia extracts might possess anticancer
activity. A large number of related species of the
Bignoniaceae are used for this purpose in traditional medi-
cine (Hartwell 1968) and also some naphthaquinones from
this family, e.g. lapachol 6, have attracted interest as poten-
tial anticancer drugs. Studies were consequently initiated
testing K. pinnata extracts in vitro for cytotoxicity against cul-
tured melanoma cells using the SRB assay for cell viability.
Initial studies showed that only the less polar
dichloromethane extracts of the stembark showed signifi-
cant effects but not extracts of the dried fruits (Houghton et
al. 1994). Later studies, however, showed that the
dichloromethane extract of the fresh fruits, and also the alco-
holic extract of the fruit used in making commercial creams,
also showed activity (Jackson et al. 1995).
Bioassay-guided fractionation, using the same cytotoxicity
bioassay system, of the dichloromethane stembark extract,
and also the fruit extract, showed that several compounds
contribute to the effect (Jackson et al. 2000). The compound
with the greatest activity, isolated from the most active frac-
tion after separation on a silica gel column, was not a naph-
Figure 4: Flavonoids and other shikimate-derived compounds  from
Kigelia pinnata
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thoquinone but the iridoid-like compound norviburtinal 5.
The steroid β-sitosterol 24 was also found in the most active
fraction but had negligible activity. Comparison of the activi-
ty of norviburtinal 5 with the amount present in the dose of
extract having the same activity showed that it did not con-
tribute to a large part of the effect e.g. norviburtinal 5 had an
IC50 of 3.25μg mL
-1 against G361 cells (144 hour exposure)
but it was calculated that its concentration in the total
dichloromethane extract (IC50 2.1μg mL
-1) was only 0.154μg
mL-1, thus indicating that other cytotoxic compounds are
present which await discovery. This was also shown by the
fact that other fractions which did not contain norviburtinal 5,
which were not investigated further, also displayed appre-
ciable activity.
Although norviburtinal 5 had a reasonably good level of
activity against the melanoma cell lines tested, it was also
cytotoxic against other cancer cell lines (Table 1), thus
reducing its suitability as a lead compound for cancer
chemotherapy. Although it does not appear to be used in tra-
ditional medicine for treating cancer, the rootbark
dichloromethane extract also showed some activity and the
naphthaquinone isopinnatal 11 was shown to play a major
contribution to this (Jackson et al. 2000).
It is of interest to note that 2mg extracts of K. pinnata fruits
from Nigeria have also shown antitumour effects when given
intraperitoneally to mice with fore-stomach tumours induced
by benzopyrene (Azuine et al. 1997). The extract alone
showed little toxicity when it was given to the mice and so
these studies give further evidence of the relative safety and
efficacy against cancer of the ethanolic extract of the fruits,
although individual compounds were not isolated.
A paper by Khan (1998) ascribed some in vitro cytotoxic
activity found in an extract of the fruits to the steroid γ-sitos-
terol 26 but this has not been confirmed by other studies. It
is interesting to note that the related β-sitosterol 24 was
found in the active fraction of K. pinnata fruit and bark but
showed no activity (Jackson et al. 2000).
There are no records of the traditional use of Kigelia pin-
nata against protozoal diseases such as malaria, leishma-
nia, sleeping sickness or Chaga’s disease although the
reports of the use of the bark in dysentery could suggest
activity against Entamoeba histolytica, the cause of amaoe-
bic dysentery. However, the occurrence of novel naphtho-
quinones prompted the investigation of antiprotozoal activity
of extracts and isolated naphthoquinoids since naphtho-
quinones exhibit antiprotozoal activity (Croft et al. 1985).
This activity is due to the increase of oxygen consumption
and stimulation of hydrogen peroxide production in the pro-
tozoal cell (Meshnick et al. 1987). Protozoa do not have the
same biochemical mechanism as mammalian cells for deal-
ing with excess peroxide and consequent oxygen free radi-
cals and so this process is used as a target in the search for
novel antiprotozoal compounds. Bioassay guided fractiona-
tion of extracts of K. pinnata rootbark and stembark was car-
ried out using in vitro cultures of Trypanosoma cruzi (the
organism associated with Chaga’s disease ) and T. brucei
rhodesiense and T. brucei brucei ( associated with sleeping
sickness) (Moideen et al. 1999). Similar studies were carried
out with Leishmania major (associated with leishmaniasis)
(Moideen 1998) and Plasmodium falciparum (the causative
agent of malaria) for which the chloroquine-resistant K1
strain was used (Weiss et al. 2000). No great dose-related
activity for extracts of compounds could be found against T.
cruzi or the amastigote forms of Leishmania major or
Trypanosoma but some activity was observed against the
other protozoa. In all cases the dichloromethane extract of
the plant material proved to be the most active and the
greatest activity was shown by 2-(1-hydroxyethyl)naph-
tho[2,3-b]furan-4,9-quinone 9, with isopinnatal 11 also show-
ing some activity. The neolignan balanophonin 23, which
was also present in the bark extracts tested, showed no
appreciable activity. In the case of activity against
Trypanosoma the activity of the furanoquinone was of the
same order of magnitude as the positive control, pentami-
dine, but the activity of the compounds against Leishmania
and Plasmodium was considerably less than that displayed
by the positive control substances (Table 2). The in vitro
cytotoxicity of the compounds was also tested using cultured
mammalian KB cells and the values obtained suggested that
the compounds had a general cytotoxic effect which tended
to preclude any clinical usefulness. It should be noted, how-
ever, that the selectivity against Trypanosoma was more
promising (Table 3) and indicated that the active compounds
might prove useful lead compounds for further studies
against these organisms.
The traditional uses of K. pinnata bark and fruits as a treat-
ment for oedema, ulcers and other sores might indicate anti-
bacterial, wound-healing and anti-inflammatory effects. In
addition to the antibacterial activity discussed above, there
is a report on the anti-inflammatory effect on rats of the
ethanolic extract of the K. pinnata fruits (Azuine et al. 1997).
The test used was the size of oedema induced by injection
of a standard dose of albumen into a rat paw. The extract at
100mg kg-1 gave a significant 54% reduction in the circum-
ference of the paw compared with the albumin alone which
was comparable with a dose of 10mg kg-1 of the positive
control indomethacin. No work has been done to elucidate
the compounds responsible.
Anecdotal reports from southern Africa also exist concern-
ing the ability of K. pinnata fruit extract to reduce skin pig-
mentation, particularly where this takes the form of freckles.
No tests have yet been carried out to investigate the validity
of this claim but it is of interest to note that quinones are
used for skin lightening in dark-skinned people and that
quinone derivatives are present in K. pinnata. 
Table 1: In vitro cytotoxicity of norviburtinal 5 against cultured cell
lines (Jackson et al. 2000)
Cell line IC50 value μM*†
G361 melanoma 22
StML11a melanoma 50
C32 melanoma 50
ACHN renal cancer 48
Colo668 colon cancer 22
* measured using the SRB assay. Figure given is the mean of three
separate determinations.
† IC50 value for vinblastine sulphate (positive control) against these
cell lines is 0.95–1.65μM
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Conclusions
Kigelia pinnata is an interesting example of a plant, used in
traditional medicine for many years, but which is now attract-
ing interest and use far beyond its original geographical
range. Experiments into the effect of Kigelia extracts, and
some of the pure compounds contained therein, on microor-
ganisms and cancer cells have shown that the traditional
use of this plant is given considerable justification. In addi-
tion, there exists some evidence for its anti-inflammatory
reputation.
The chemical basis of these effects, particularly in the
area of anticancer and anti-inflammatory activity, has not
been elucidated to any great extent. As well as the possibil-
ity of the discovery of novel single chemical entity drugs, this
exercise is necessary so that extracts can be standardised
for minimum content of active constituents to assure the
user of efficacy. In some cases, standardisation will also
indicate safety, if the content of toxic compounds is specified
to be non-detectable or to be kept below a specified level. It
would not be surprising if deeper investigations revealed
that other compounds were present which had cytotoxic
effects which might underlie its reputation as an anticancer
drug. Similarly, work needs to be carried out to determine
whether the use of extracts to remove pigmentation has any
scientific basis and, if so, which compounds are responsible.
It would be useful to screen samples of Kigelia obtained
from different locations for chemical content and biological
activity to find out whether variation exists and, if it does,
whether it is responsible for the different traditional uses
reported from different areas.
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Compound IC50 KB/ED50 IC50 Vero/ED50 IC50 KB/ED50 IC50 Vero/ED50 IC50 KB/ED50 IC50 Vero/ED50 IC50 KB/ED50
L. major L. major Trypanosoma Trypanosoma T. brucei T. brucei Plasmodium
promastigotes promastigotes brucei brucei brucei brucei rhodesiense rhodesiense falciparum K1
trypomastigotes trypomastigotes trypomastigotes trypomastigotes (chloroquine
resistant)
2-(1-Hydroxyethyl)- 2.2 1.86 33.6 85.5 28.2 71.8 0.70
naphtho[2,3-b]furan
-4,9-quinone 9
Isopinnatal 11 8.5 9.42 41.8 20.0 46.2 22.2 0.59
Kigelinol 12 6.1 5.0 35.1 7.0 28.9 5.7 ND
Isokigelinol 13 13.4 9.23 122.6 15.1 84.7 10.4 ND
Balanophonin 23 3.72 5.76 ND ND ND ND ND
Positive control 7.4 284 710 284 435 174 861
(Pentamidine) (Chloroquine
diphosphate)
ND = not done
Table 3: Selectivity ratio of cytotoxicity of compounds isolated from Kigelia pinnata stembark between protozoa and mammalian cell lines
(Moideen 1998, Moideen et al. 1999, Weiss et al. 2000)
Table 2: In vitro antiprotozoal activity (IC50 in μM) of compounds isolated from Kigelia pinnata stem bark (Moideen 1998, Moideen et al. 1999,
Weiss et al. 2000)
Compound Leishmania major Trypanosoma brucei Trypanosoma brucei Plasmodium falciparum
promastigotes brucei trypomastigotes rhodesiense trypomastigotes K1 (chloroquine resistant)
2-(1-Hydroxyethyl)-naphtho 1.77 0.12 0.045 5.23
[2,3-b]furan-4,9-quinone 9
Isopinnatal 11 1.74 0.37 0.73 25.1
Kigelinol 12 24.4 4.21 21.3 >100
Isokigelinol 13 12.46 1.36 11.1 >100
Balanophonin 23 2.76 ND ND >100
Positive control (Pentamidine) 0.578 0.007 0.016 0.228
(Chloroquine phosphate)
ND = not done
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